Individual or Group Hypnotherapy in the treatment of Irritable Bowel Syndrome in primary and secondary care.

Completed

Conditions: Irritable Bowel Syndrome
unexplained abdominal symptoms
10017977

Registration Number: NL-OMON39767

Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 354

Inclusion Criteria

Patients aged 18-65 years in primary and secondary care , who are diagnosed with IBS (Rome III criteria)

Exclusion Criteria

Patients unable to understand the content of the sessions, because of insufficient command of the Dutch language.
Patients unable to fill in the questionnaires.
Patients unable (for example: too aggressive) or unwilling to function in a group.
Patients in whom a` psychiatric condition needs attention first (for example severe depression or psychosis).
Patients who have IBS and other chronic bowel diseases, as far as they are already diagnosed, such as ulcerative colitis, Crohn*s disease or coeliac disease.
Patients who have undergone major surgery to the lower gastrointestinal tract, such as partial or total colectomy, small bowel resection or partial or total gastrectomy.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary efficacy parameter is the responder rate for IBS symptoms based on<br /><br>a weekly assessment of Adequate Relief (AR) score.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary efficacy parameters are changes in the IBS Symptom Severity Score<br /><br>(IBS-SSS) and Quality of Life (IBS-Qol), cognitions, self-efficacy,<br /><br>psychological complaints and direct and indirect costs of the disease, measured<br /><br>as the costs of visits to doctors and alternative healers, use of medicines and<br /><br>loss of labour productiveness.</p><br>